PHILADELPHIA – Researchers from the Abramson Cancer Center (ACC) of the University of Pennsylvania and Penn’s Perelman School of Medicine will present data on the latest advances in cancer science and medicine at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 – June 3 in Chicago. For updates, follow Penn Medicine on LinkedIn , Threads , and X , and PennMD Forum on X .
Expert interviews
Oncology experts from Penn Medicine are available to comment on a wide range of cancer research and care topics during the meeting by video call, phone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu or 267-693-6224.
News releases
Susan Domchek honored by ASCO for cancer prevention work
Domchek will deliver her ASCO-ACS Cancer Prevention Award Lecture, “The Long Road to Breast Cancer Risk and Genetics-Informed Precision Prevention” on Monday, June 2 at 9:45 a.m. CT in S100bc. Check back for more updates during the meeting.
Key presentations
Penn Medicine researchers will present several updates in clinical research, including new Phase I clinical trial data on CAR T cell therapy for glioblastoma, five-year follow-up data on belzutifan for von Hippel-Lindau (VHL) disease, and Phase II clinical data on immunotherapy before surgery in early-stage melanoma.
Researchers from Penn Medicine’s Basser Center for BRCA , the first center dedicated to the research, treatment, and prevention of BRCA-related cancers, will present two studies in the Prevention, Risk Reduction, and Genetics Oral Abstract Session on Monday, June 2 at 11:30am CT in S100a. This research highlights the Basser Center’s comprehensive mission, from genetic testing to cancer interception.
###
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $580 million awarded in the 2023 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Doylestown Health, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.9 billion enterprise powered by nearly 49,000 talented faculty and staff.